Skip to search formSkip to main contentSkip to account menu

D 19466

Known as: D-19466 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

lobaplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Phase I clinical trial of Lobaplatin ( D-19466 ) after intravenous bolus injection
Fiebig HH, et al.: Phase I clinical trial of Lobaplatin (D-19466) after intravenous bolus injection. Onkologie 1994;17:142-148… 
2005
2005
D-19466, a new cyclobutane-platinum complex with antitumor activity
SummaryD-19466, a new platinum complex, was characterized. It showed no nephrotoxic side-effects as determined by the measurement… 
1996
1996
Lobaplatin (D-19466) in Patients with Advanced Non-Small-Cell Lung Cancer: A Trial of the Association for Medical Oncology (AIO) Phase II Study Group
Background: Lobaplatin, D-19466, 1,2-diaminomethyl cyclo-butane ρlatinum(II)lactate, is a new, water-soluble platinum complex… 
1996
1996
Determination of the two diastereoisomers of lobaplatin (D-19466) in plasma ultrafiltrate of cancer patients with a normal or an impaired kidney or liver function by high-performance liquid…
1995
1995
A trial of lobaplatin (D-19466) in platinum-resistant ovarian cancer.
Long-term survival in epithelial ovarian cancer remains problematic despite multimodality therapy. A fundamental difficulty is… 
1994
1994
Phase I Clinical Trial of Lobaplatin (D-19466) after Intravenous Bolus Injection
Backgrund : Lobaplatin, D-19466, l,2-diamminomethyl-cyclobutane-platinum-(II)-lactate, is a new watersoluble platin complex which… 
1993
1993
A PHASE-I STUDY OF IOBAPLATIN (D-19466) ADMINISTERED BY 72H CONTINUOUS INFUSION
A phase I trial with continuous intravenous infusion of lobaplatin (D-19466; 1,2-diamminomethyl-cyclobutane-platinum (II)-lactate… 
1993
1993
A phase I study of lobaplatin (D-19466) administered by 72 h continuous infusion
A phase I trial with continuous intravenous infusion of lobaplatin (D-19466; 1,2-diamminomethyl-cyclobutaneplatinum (ll)-lactate… 
1992
1992
Pharmacokinetic and Pharmacodynamic Study with Lobaplatin (D-19466), a New Platinum Complex, after Bolus Administration
Background: Lobaplatin (D-19466) is a platinum compound with greater anticancer activity in NSCLC, stomach, breast and ovarian… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)